Quote | Shattuck Labs Inc. (NASDAQ:STTK)
Last: | $3.64 |
---|---|
Change Percent: | 1.25% |
Open: | $3.94 |
Close: | $3.64 |
High: | $3.99 |
Low: | $3.63 |
Volume: | 385,895 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Shattuck Labs Inc. (NASDAQ:STTK)
2024-06-14 19:15:01 ET BTIG analyst issues NEUTRAL recommendation for STTK on June 14, 2024 05:34PM ET. STTK was trading at $6.19 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendations . ...
2024-06-14 07:07:40 ET More on Shattuck Labs Seeking Alpha’s Quant Rating on Shattuck Labs Historical earnings data for Shattuck Labs Financial information for Shattuck Labs Read the full article on Seeking Alpha For further details see: Sh...
Message Board Posts | Shattuck Labs Inc. (NASDAQ:STTK)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
2024-06-14 19:15:01 ET BTIG analyst issues NEUTRAL recommendation for STTK on June 14, 2024 05:34PM ET. STTK was trading at $6.19 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendations . ...
– Observed 67% Objective Response Rate (ORR) in frontline HR-MDS patients, primarily with TP53 mutations; initial complete remission (CR)/marrow complete remission (mCR) rate of 58% and median overall survival had not yet been reached – – Observed 43% ORR in frontli...
AUSTIN, TX and DURHAM, NC, June 10, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (Nasdaq: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmun...